nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—CYP2D6—Fingolimod—multiple sclerosis	0.038	0.121	CbGbCtD
Aripiprazole—ABCB1—Methylprednisolone—multiple sclerosis	0.026	0.083	CbGbCtD
Aripiprazole—CYP3A4—Fingolimod—multiple sclerosis	0.0241	0.0772	CbGbCtD
Aripiprazole—HTR1B—trigeminal nucleus—multiple sclerosis	0.021	0.113	CbGeAlD
Aripiprazole—HTR1D—trigeminal nucleus—multiple sclerosis	0.0203	0.109	CbGeAlD
Aripiprazole—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0201	0.0643	CbGbCtD
Aripiprazole—CYP3A7—Dexamethasone—multiple sclerosis	0.0201	0.0643	CbGbCtD
Aripiprazole—ABCB1—Mitoxantrone—multiple sclerosis	0.0189	0.0606	CbGbCtD
Aripiprazole—HTR3A—area postrema—multiple sclerosis	0.0185	0.0991	CbGeAlD
Aripiprazole—ABCB1—Betamethasone—multiple sclerosis	0.0169	0.054	CbGbCtD
Aripiprazole—ABCB1—Prednisolone—multiple sclerosis	0.0167	0.0533	CbGbCtD
Aripiprazole—ABCB1—Prednisone—multiple sclerosis	0.0157	0.0503	CbGbCtD
Aripiprazole—CYP3A4—Methylprednisolone—multiple sclerosis	0.0156	0.0498	CbGbCtD
Aripiprazole—CYP3A5—Dexamethasone—multiple sclerosis	0.0151	0.0483	CbGbCtD
Aripiprazole—HTR1D—meninx—multiple sclerosis	0.0135	0.0725	CbGeAlD
Aripiprazole—CYP3A4—Triamcinolone—multiple sclerosis	0.0118	0.0377	CbGbCtD
Aripiprazole—CYP3A4—Mitoxantrone—multiple sclerosis	0.0114	0.0363	CbGbCtD
Aripiprazole—CYP3A4—Betamethasone—multiple sclerosis	0.0101	0.0324	CbGbCtD
Aripiprazole—HTR2A—trigeminal nucleus—multiple sclerosis	0.0101	0.0542	CbGeAlD
Aripiprazole—CYP3A4—Prednisolone—multiple sclerosis	0.00998	0.0319	CbGbCtD
Aripiprazole—ABCB1—Dexamethasone—multiple sclerosis	0.00982	0.0314	CbGbCtD
Aripiprazole—CYP3A4—Prednisone—multiple sclerosis	0.00943	0.0301	CbGbCtD
Aripiprazole—CYP2D6—Dexamethasone—multiple sclerosis	0.00926	0.0296	CbGbCtD
Aripiprazole—ABCB1—Methotrexate—multiple sclerosis	0.00789	0.0252	CbGbCtD
Aripiprazole—CYP3A4—Dexamethasone—multiple sclerosis	0.00589	0.0188	CbGbCtD
Aripiprazole—HTR1B—trigeminal nerve—multiple sclerosis	0.00552	0.0296	CbGeAlD
Aripiprazole—HTR1D—trigeminal nerve—multiple sclerosis	0.00534	0.0287	CbGeAlD
Aripiprazole—HTR7—pons—multiple sclerosis	0.003	0.0161	CbGeAlD
Aripiprazole—HTR2A—trigeminal nerve—multiple sclerosis	0.00265	0.0142	CbGeAlD
Aripiprazole—DRD1—nerve—multiple sclerosis	0.00249	0.0133	CbGeAlD
Aripiprazole—HTR3A—nerve—multiple sclerosis	0.0024	0.0129	CbGeAlD
Aripiprazole—HTR7—peripheral nervous system—multiple sclerosis	0.00199	0.0107	CbGeAlD
Aripiprazole—HTR2A—pons—multiple sclerosis	0.00187	0.01	CbGeAlD
Aripiprazole—HTR1E—brainstem—multiple sclerosis	0.00183	0.00981	CbGeAlD
Aripiprazole—HTR7—nerve—multiple sclerosis	0.00155	0.00834	CbGeAlD
Aripiprazole—DRD2—nerve—multiple sclerosis	0.00147	0.00788	CbGeAlD
Aripiprazole—ADRA2A—peripheral nervous system—multiple sclerosis	0.00146	0.00785	CbGeAlD
Aripiprazole—HTR2A—pineal body—multiple sclerosis	0.00133	0.00716	CbGeAlD
Aripiprazole—HTR2A—peripheral nervous system—multiple sclerosis	0.00124	0.00667	CbGeAlD
Aripiprazole—DRD1—brainstem—multiple sclerosis	0.00107	0.00573	CbGeAlD
Aripiprazole—H1F0—retina—multiple sclerosis	0.00104	0.0056	CbGeAlD
Aripiprazole—HTR3A—brainstem—multiple sclerosis	0.00103	0.00553	CbGeAlD
Aripiprazole—HTR2A—nerve—multiple sclerosis	0.000969	0.0052	CbGeAlD
Aripiprazole—HTR1E—nervous system—multiple sclerosis	0.000958	0.00514	CbGeAlD
Aripiprazole—HTR1E—central nervous system—multiple sclerosis	0.000922	0.00495	CbGeAlD
Aripiprazole—HTR1B—brainstem—multiple sclerosis	0.000865	0.00464	CbGeAlD
Aripiprazole—DRD4—brain—multiple sclerosis	0.000849	0.00456	CbGeAlD
Aripiprazole—CHRM4—nervous system—multiple sclerosis	0.00084	0.00451	CbGeAlD
Aripiprazole—HTR1D—brainstem—multiple sclerosis	0.000837	0.00449	CbGeAlD
Aripiprazole—HTR2C—brainstem—multiple sclerosis	0.000829	0.00445	CbGeAlD
Aripiprazole—CHRM4—central nervous system—multiple sclerosis	0.000809	0.00434	CbGeAlD
Aripiprazole—SLC6A4—brainstem—multiple sclerosis	0.000786	0.00422	CbGeAlD
Aripiprazole—DRD3—nervous system—multiple sclerosis	0.000781	0.00419	CbGeAlD
Aripiprazole—H1F0—medulla oblongata—multiple sclerosis	0.000754	0.00405	CbGeAlD
Aripiprazole—DRD3—central nervous system—multiple sclerosis	0.000752	0.00404	CbGeAlD
Aripiprazole—HTR6—nervous system—multiple sclerosis	0.000752	0.00403	CbGeAlD
Aripiprazole—HTR1E—brain—multiple sclerosis	0.000732	0.00393	CbGeAlD
Aripiprazole—DRD5—nervous system—multiple sclerosis	0.000732	0.00393	CbGeAlD
Aripiprazole—HTR6—central nervous system—multiple sclerosis	0.000724	0.00388	CbGeAlD
Aripiprazole—DRD5—central nervous system—multiple sclerosis	0.000705	0.00378	CbGeAlD
Aripiprazole—HTR1A—brainstem—multiple sclerosis	0.000698	0.00375	CbGeAlD
Aripiprazole—H1F0—midbrain—multiple sclerosis	0.000689	0.0037	CbGeAlD
Aripiprazole—DRD1—midbrain—multiple sclerosis	0.00068	0.00365	CbGeAlD
Aripiprazole—H1F0—spinal cord—multiple sclerosis	0.000672	0.00361	CbGeAlD
Aripiprazole—HTR7—brainstem—multiple sclerosis	0.000667	0.00358	CbGeAlD
Aripiprazole—CHRM5—nervous system—multiple sclerosis	0.000657	0.00352	CbGeAlD
Aripiprazole—ADRA1A—brainstem—multiple sclerosis	0.000643	0.00345	CbGeAlD
Aripiprazole—CHRM4—brain—multiple sclerosis	0.000642	0.00345	CbGeAlD
Aripiprazole—CHRM5—central nervous system—multiple sclerosis	0.000632	0.00339	CbGeAlD
Aripiprazole—DRD2—brainstem—multiple sclerosis	0.000631	0.00338	CbGeAlD
Aripiprazole—DRD2—retina—multiple sclerosis	0.000608	0.00327	CbGeAlD
Aripiprazole—ADRA1B—nervous system—multiple sclerosis	0.0006	0.00322	CbGeAlD
Aripiprazole—DRD3—brain—multiple sclerosis	0.000597	0.0032	CbGeAlD
Aripiprazole—HTR2C—medulla oblongata—multiple sclerosis	0.000578	0.0031	CbGeAlD
Aripiprazole—ADRA1B—central nervous system—multiple sclerosis	0.000578	0.0031	CbGeAlD
Aripiprazole—HTR6—brain—multiple sclerosis	0.000575	0.00308	CbGeAlD
Aripiprazole—H1F0—nervous system—multiple sclerosis	0.000566	0.00304	CbGeAlD
Aripiprazole—DRD5—brain—multiple sclerosis	0.000559	0.003	CbGeAlD
Aripiprazole—DRD1—nervous system—multiple sclerosis	0.000559	0.003	CbGeAlD
Aripiprazole—HTR1B—midbrain—multiple sclerosis	0.000551	0.00296	CbGeAlD
Aripiprazole—H1F0—central nervous system—multiple sclerosis	0.000545	0.00293	CbGeAlD
Aripiprazole—HTR3A—nervous system—multiple sclerosis	0.00054	0.0029	CbGeAlD
Aripiprazole—DRD1—central nervous system—multiple sclerosis	0.000538	0.00289	CbGeAlD
Aripiprazole—HTR1B—spinal cord—multiple sclerosis	0.000538	0.00289	CbGeAlD
Aripiprazole—HTR1D—midbrain—multiple sclerosis	0.000534	0.00286	CbGeAlD
Aripiprazole—H1F0—cerebellum—multiple sclerosis	0.000533	0.00286	CbGeAlD
Aripiprazole—HTR2C—midbrain—multiple sclerosis	0.000528	0.00284	CbGeAlD
Aripiprazole—HTR3A—central nervous system—multiple sclerosis	0.00052	0.00279	CbGeAlD
Aripiprazole—HTR2C—spinal cord—multiple sclerosis	0.000516	0.00277	CbGeAlD
Aripiprazole—CHRM5—brain—multiple sclerosis	0.000502	0.00269	CbGeAlD
Aripiprazole—SLC6A4—midbrain—multiple sclerosis	0.000501	0.00269	CbGeAlD
Aripiprazole—SLC6A4—spinal cord—multiple sclerosis	0.000489	0.00262	CbGeAlD
Aripiprazole—HTR7—medulla oblongata—multiple sclerosis	0.000465	0.0025	CbGeAlD
Aripiprazole—ADRA1B—brain—multiple sclerosis	0.000459	0.00246	CbGeAlD
Aripiprazole—HTR1B—nervous system—multiple sclerosis	0.000453	0.00243	CbGeAlD
Aripiprazole—CHRM2—nervous system—multiple sclerosis	0.000451	0.00242	CbGeAlD
Aripiprazole—HTR1A—midbrain—multiple sclerosis	0.000445	0.00239	CbGeAlD
Aripiprazole—HTR1D—nervous system—multiple sclerosis	0.000439	0.00235	CbGeAlD
Aripiprazole—HTR1B—central nervous system—multiple sclerosis	0.000436	0.00234	CbGeAlD
Aripiprazole—HTR2C—nervous system—multiple sclerosis	0.000434	0.00233	CbGeAlD
Aripiprazole—HTR1A—spinal cord—multiple sclerosis	0.000434	0.00233	CbGeAlD
Aripiprazole—CHRM2—central nervous system—multiple sclerosis	0.000434	0.00233	CbGeAlD
Aripiprazole—KCNH2—medulla oblongata—multiple sclerosis	0.000433	0.00233	CbGeAlD
Aripiprazole—H1F0—brain—multiple sclerosis	0.000433	0.00232	CbGeAlD
Aripiprazole—ADRA2C—medulla oblongata—multiple sclerosis	0.000427	0.00229	CbGeAlD
Aripiprazole—DRD1—brain—multiple sclerosis	0.000427	0.00229	CbGeAlD
Aripiprazole—ADRB1—nervous system—multiple sclerosis	0.000426	0.00229	CbGeAlD
Aripiprazole—HTR7—midbrain—multiple sclerosis	0.000425	0.00228	CbGeAlD
Aripiprazole—HTR1D—central nervous system—multiple sclerosis	0.000422	0.00227	CbGeAlD
Aripiprazole—HTR2C—central nervous system—multiple sclerosis	0.000418	0.00224	CbGeAlD
Aripiprazole—HTR2A—brainstem—multiple sclerosis	0.000416	0.00223	CbGeAlD
Aripiprazole—HTR7—spinal cord—multiple sclerosis	0.000415	0.00223	CbGeAlD
Aripiprazole—HTR3A—brain—multiple sclerosis	0.000413	0.00222	CbGeAlD
Aripiprazole—SLC6A4—nervous system—multiple sclerosis	0.000412	0.00221	CbGeAlD
Aripiprazole—ADRB1—central nervous system—multiple sclerosis	0.00041	0.0022	CbGeAlD
Aripiprazole—CHRM1—nervous system—multiple sclerosis	0.00041	0.0022	CbGeAlD
Aripiprazole—HTR2B—nervous system—multiple sclerosis	0.000408	0.00219	CbGeAlD
Aripiprazole—DRD2—midbrain—multiple sclerosis	0.000402	0.00216	CbGeAlD
Aripiprazole—HTR2A—retina—multiple sclerosis	0.000401	0.00215	CbGeAlD
Aripiprazole—SLC6A4—central nervous system—multiple sclerosis	0.000396	0.00213	CbGeAlD
Aripiprazole—KCNH2—midbrain—multiple sclerosis	0.000396	0.00213	CbGeAlD
Aripiprazole—CHRM1—central nervous system—multiple sclerosis	0.000395	0.00212	CbGeAlD
Aripiprazole—HTR2B—central nervous system—multiple sclerosis	0.000393	0.00211	CbGeAlD
Aripiprazole—ADRA2C—midbrain—multiple sclerosis	0.000391	0.0021	CbGeAlD
Aripiprazole—KCNH2—spinal cord—multiple sclerosis	0.000386	0.00207	CbGeAlD
Aripiprazole—ADRA2C—spinal cord—multiple sclerosis	0.000381	0.00205	CbGeAlD
Aripiprazole—CYP2D6—brainstem—multiple sclerosis	0.000379	0.00203	CbGeAlD
Aripiprazole—CHRM3—nervous system—multiple sclerosis	0.000367	0.00197	CbGeAlD
Aripiprazole—HTR1A—nervous system—multiple sclerosis	0.000366	0.00196	CbGeAlD
Aripiprazole—CHRM3—central nervous system—multiple sclerosis	0.000353	0.0019	CbGeAlD
Aripiprazole—HTR1A—central nervous system—multiple sclerosis	0.000352	0.00189	CbGeAlD
Aripiprazole—HTR7—nervous system—multiple sclerosis	0.000349	0.00188	CbGeAlD
Aripiprazole—HTR1B—brain—multiple sclerosis	0.000346	0.00186	CbGeAlD
Aripiprazole—CHRM2—brain—multiple sclerosis	0.000344	0.00185	CbGeAlD
Aripiprazole—HTR1A—cerebellum—multiple sclerosis	0.000344	0.00185	CbGeAlD
Aripiprazole—ADRA2A—medulla oblongata—multiple sclerosis	0.000341	0.00183	CbGeAlD
Aripiprazole—ADRA1A—nervous system—multiple sclerosis	0.000337	0.00181	CbGeAlD
Aripiprazole—HTR7—central nervous system—multiple sclerosis	0.000336	0.00181	CbGeAlD
Aripiprazole—HTR1D—brain—multiple sclerosis	0.000335	0.0018	CbGeAlD
Aripiprazole—HTR2C—brain—multiple sclerosis	0.000332	0.00178	CbGeAlD
Aripiprazole—DRD2—nervous system—multiple sclerosis	0.00033	0.00177	CbGeAlD
Aripiprazole—HTR7—cerebellum—multiple sclerosis	0.000329	0.00176	CbGeAlD
Aripiprazole—ADRB1—brain—multiple sclerosis	0.000326	0.00175	CbGeAlD
Aripiprazole—KCNH2—nervous system—multiple sclerosis	0.000326	0.00175	CbGeAlD
Aripiprazole—ADRA1A—central nervous system—multiple sclerosis	0.000324	0.00174	CbGeAlD
Aripiprazole—ADRA2C—nervous system—multiple sclerosis	0.000321	0.00172	CbGeAlD
Aripiprazole—DRD2—central nervous system—multiple sclerosis	0.000318	0.00171	CbGeAlD
Aripiprazole—ADRA1A—cerebellum—multiple sclerosis	0.000317	0.0017	CbGeAlD
Aripiprazole—SLC6A4—brain—multiple sclerosis	0.000315	0.00169	CbGeAlD
Aripiprazole—CHRM1—brain—multiple sclerosis	0.000314	0.00168	CbGeAlD
Aripiprazole—KCNH2—central nervous system—multiple sclerosis	0.000313	0.00168	CbGeAlD
Aripiprazole—HTR2B—brain—multiple sclerosis	0.000312	0.00167	CbGeAlD
Aripiprazole—ADRA2A—midbrain—multiple sclerosis	0.000312	0.00167	CbGeAlD
Aripiprazole—DRD2—cerebellum—multiple sclerosis	0.000311	0.00167	CbGeAlD
Aripiprazole—ADRA2C—central nervous system—multiple sclerosis	0.000309	0.00166	CbGeAlD
Aripiprazole—KCNH2—cerebellum—multiple sclerosis	0.000306	0.00164	CbGeAlD
Aripiprazole—ADRA2A—spinal cord—multiple sclerosis	0.000304	0.00163	CbGeAlD
Aripiprazole—ADRA2C—cerebellum—multiple sclerosis	0.000302	0.00162	CbGeAlD
Aripiprazole—HTR2A—medulla oblongata—multiple sclerosis	0.00029	0.00156	CbGeAlD
Aripiprazole—CHRM3—brain—multiple sclerosis	0.000281	0.00151	CbGeAlD
Aripiprazole—HTR1A—brain—multiple sclerosis	0.000279	0.0015	CbGeAlD
Aripiprazole—HTR7—brain—multiple sclerosis	0.000267	0.00143	CbGeAlD
Aripiprazole—HTR2A—midbrain—multiple sclerosis	0.000265	0.00142	CbGeAlD
Aripiprazole—ABCB1—retina—multiple sclerosis	0.000263	0.00141	CbGeAlD
Aripiprazole—HRH1—nervous system—multiple sclerosis	0.000261	0.0014	CbGeAlD
Aripiprazole—HTR2A—spinal cord—multiple sclerosis	0.000259	0.00139	CbGeAlD
Aripiprazole—ADRA1A—brain—multiple sclerosis	0.000258	0.00138	CbGeAlD
Aripiprazole—ADRA2A—nervous system—multiple sclerosis	0.000256	0.00138	CbGeAlD
Aripiprazole—DRD2—brain—multiple sclerosis	0.000253	0.00136	CbGeAlD
Aripiprazole—HRH1—central nervous system—multiple sclerosis	0.000251	0.00135	CbGeAlD
Aripiprazole—KCNH2—brain—multiple sclerosis	0.000249	0.00134	CbGeAlD
Aripiprazole—ADRA2A—central nervous system—multiple sclerosis	0.000247	0.00132	CbGeAlD
Aripiprazole—ADRA2C—brain—multiple sclerosis	0.000245	0.00132	CbGeAlD
Aripiprazole—ADRA2A—cerebellum—multiple sclerosis	0.000241	0.00129	CbGeAlD
Aripiprazole—HTR2A—nervous system—multiple sclerosis	0.000218	0.00117	CbGeAlD
Aripiprazole—HTR2A—central nervous system—multiple sclerosis	0.00021	0.00113	CbGeAlD
Aripiprazole—HTR2A—cerebellum—multiple sclerosis	0.000205	0.0011	CbGeAlD
Aripiprazole—CYP3A4—nervous system—multiple sclerosis	0.000202	0.00108	CbGeAlD
Aripiprazole—HRH1—brain—multiple sclerosis	0.000199	0.00107	CbGeAlD
Aripiprazole—CYP2D6—nervous system—multiple sclerosis	0.000199	0.00107	CbGeAlD
Aripiprazole—ADRA2A—brain—multiple sclerosis	0.000196	0.00105	CbGeAlD
Aripiprazole—CYP3A4—central nervous system—multiple sclerosis	0.000194	0.00104	CbGeAlD
Aripiprazole—CYP2D6—central nervous system—multiple sclerosis	0.000191	0.00103	CbGeAlD
Aripiprazole—ABCB1—medulla oblongata—multiple sclerosis	0.00019	0.00102	CbGeAlD
Aripiprazole—CYP2D6—cerebellum—multiple sclerosis	0.000187	0.001	CbGeAlD
Aripiprazole—ABCB1—midbrain—multiple sclerosis	0.000174	0.000932	CbGeAlD
Aripiprazole—ABCB1—spinal cord—multiple sclerosis	0.000169	0.00091	CbGeAlD
Aripiprazole—HTR2A—brain—multiple sclerosis	0.000167	0.000894	CbGeAlD
Aripiprazole—CYP2D6—brain—multiple sclerosis	0.000152	0.000814	CbGeAlD
Aripiprazole—ABCB1—nervous system—multiple sclerosis	0.000143	0.000766	CbGeAlD
Aripiprazole—ABCB1—central nervous system—multiple sclerosis	0.000137	0.000738	CbGeAlD
Aripiprazole—ABCB1—cerebellum—multiple sclerosis	0.000134	0.000721	CbGeAlD
Aripiprazole—ABCB1—brain—multiple sclerosis	0.000109	0.000586	CbGeAlD
Aripiprazole—Tachycardia—Methylprednisolone—multiple sclerosis	9.41e-05	0.000287	CcSEcCtD
Aripiprazole—Skin disorder—Methylprednisolone—multiple sclerosis	9.36e-05	0.000285	CcSEcCtD
Aripiprazole—Malnutrition—Prednisone—multiple sclerosis	9.35e-05	0.000285	CcSEcCtD
Aripiprazole—Erythema—Prednisone—multiple sclerosis	9.35e-05	0.000285	CcSEcCtD
Aripiprazole—Hyperhidrosis—Triamcinolone—multiple sclerosis	9.34e-05	0.000285	CcSEcCtD
Aripiprazole—Agranulocytosis—Methotrexate—multiple sclerosis	9.33e-05	0.000285	CcSEcCtD
Aripiprazole—Hyperhidrosis—Methylprednisolone—multiple sclerosis	9.32e-05	0.000284	CcSEcCtD
Aripiprazole—Convulsion—Dexamethasone—multiple sclerosis	9.3e-05	0.000284	CcSEcCtD
Aripiprazole—Convulsion—Betamethasone—multiple sclerosis	9.3e-05	0.000284	CcSEcCtD
Aripiprazole—Hypertension—Dexamethasone—multiple sclerosis	9.27e-05	0.000283	CcSEcCtD
Aripiprazole—Hypertension—Betamethasone—multiple sclerosis	9.27e-05	0.000283	CcSEcCtD
Aripiprazole—Asthenia—Mitoxantrone—multiple sclerosis	9.19e-05	0.00028	CcSEcCtD
Aripiprazole—Myalgia—Dexamethasone—multiple sclerosis	9.14e-05	0.000279	CcSEcCtD
Aripiprazole—Myalgia—Betamethasone—multiple sclerosis	9.14e-05	0.000279	CcSEcCtD
Aripiprazole—Anxiety—Betamethasone—multiple sclerosis	9.11e-05	0.000278	CcSEcCtD
Aripiprazole—Anxiety—Dexamethasone—multiple sclerosis	9.11e-05	0.000278	CcSEcCtD
Aripiprazole—Discomfort—Betamethasone—multiple sclerosis	9.03e-05	0.000275	CcSEcCtD
Aripiprazole—Discomfort—Dexamethasone—multiple sclerosis	9.03e-05	0.000275	CcSEcCtD
Aripiprazole—Haemoglobin—Methotrexate—multiple sclerosis	9.02e-05	0.000275	CcSEcCtD
Aripiprazole—Hypotension—Methylprednisolone—multiple sclerosis	9.01e-05	0.000275	CcSEcCtD
Aripiprazole—Pain—Prednisolone—multiple sclerosis	8.98e-05	0.000274	CcSEcCtD
Aripiprazole—Haemorrhage—Methotrexate—multiple sclerosis	8.98e-05	0.000274	CcSEcCtD
Aripiprazole—Hepatitis—Methotrexate—multiple sclerosis	8.98e-05	0.000274	CcSEcCtD
Aripiprazole—Pharyngitis—Methotrexate—multiple sclerosis	8.91e-05	0.000272	CcSEcCtD
Aripiprazole—Urinary tract disorder—Methotrexate—multiple sclerosis	8.87e-05	0.00027	CcSEcCtD
Aripiprazole—Vision blurred—Prednisone—multiple sclerosis	8.81e-05	0.000269	CcSEcCtD
Aripiprazole—Urethral disorder—Methotrexate—multiple sclerosis	8.8e-05	0.000268	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	8.8e-05	0.000268	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	8.78e-05	0.000268	CcSEcCtD
Aripiprazole—Anaphylactic shock—Dexamethasone—multiple sclerosis	8.76e-05	0.000267	CcSEcCtD
Aripiprazole—Anaphylactic shock—Betamethasone—multiple sclerosis	8.76e-05	0.000267	CcSEcCtD
Aripiprazole—Oedema—Betamethasone—multiple sclerosis	8.76e-05	0.000267	CcSEcCtD
Aripiprazole—Oedema—Dexamethasone—multiple sclerosis	8.76e-05	0.000267	CcSEcCtD
Aripiprazole—Diarrhoea—Mitoxantrone—multiple sclerosis	8.76e-05	0.000267	CcSEcCtD
Aripiprazole—Insomnia—Triamcinolone—multiple sclerosis	8.74e-05	0.000266	CcSEcCtD
Aripiprazole—Insomnia—Methylprednisolone—multiple sclerosis	8.72e-05	0.000266	CcSEcCtD
Aripiprazole—Infection—Dexamethasone—multiple sclerosis	8.71e-05	0.000265	CcSEcCtD
Aripiprazole—Infection—Betamethasone—multiple sclerosis	8.71e-05	0.000265	CcSEcCtD
Aripiprazole—Ill-defined disorder—Prednisone—multiple sclerosis	8.68e-05	0.000265	CcSEcCtD
Aripiprazole—Paraesthesia—Triamcinolone—multiple sclerosis	8.67e-05	0.000264	CcSEcCtD
Aripiprazole—Feeling abnormal—Prednisolone—multiple sclerosis	8.66e-05	0.000264	CcSEcCtD
Aripiprazole—Paraesthesia—Methylprednisolone—multiple sclerosis	8.65e-05	0.000264	CcSEcCtD
Aripiprazole—Visual impairment—Methotrexate—multiple sclerosis	8.65e-05	0.000264	CcSEcCtD
Aripiprazole—Anaemia—Prednisone—multiple sclerosis	8.64e-05	0.000264	CcSEcCtD
Aripiprazole—Shock—Dexamethasone—multiple sclerosis	8.62e-05	0.000263	CcSEcCtD
Aripiprazole—Shock—Betamethasone—multiple sclerosis	8.62e-05	0.000263	CcSEcCtD
Aripiprazole—Dyspnoea—Triamcinolone—multiple sclerosis	8.61e-05	0.000263	CcSEcCtD
Aripiprazole—Nervous system disorder—Betamethasone—multiple sclerosis	8.6e-05	0.000262	CcSEcCtD
Aripiprazole—Nervous system disorder—Dexamethasone—multiple sclerosis	8.6e-05	0.000262	CcSEcCtD
Aripiprazole—Agitation—Prednisone—multiple sclerosis	8.59e-05	0.000262	CcSEcCtD
Aripiprazole—Thrombocytopenia—Dexamethasone—multiple sclerosis	8.58e-05	0.000262	CcSEcCtD
Aripiprazole—Thrombocytopenia—Betamethasone—multiple sclerosis	8.58e-05	0.000262	CcSEcCtD
Aripiprazole—Tachycardia—Betamethasone—multiple sclerosis	8.55e-05	0.000261	CcSEcCtD
Aripiprazole—Tachycardia—Dexamethasone—multiple sclerosis	8.55e-05	0.000261	CcSEcCtD
Aripiprazole—Angioedema—Prednisone—multiple sclerosis	8.55e-05	0.000261	CcSEcCtD
Aripiprazole—Dyspepsia—Triamcinolone—multiple sclerosis	8.5e-05	0.000259	CcSEcCtD
Aripiprazole—Dyspepsia—Methylprednisolone—multiple sclerosis	8.48e-05	0.000259	CcSEcCtD
Aripiprazole—Hyperhidrosis—Betamethasone—multiple sclerosis	8.47e-05	0.000258	CcSEcCtD
Aripiprazole—Hyperhidrosis—Dexamethasone—multiple sclerosis	8.47e-05	0.000258	CcSEcCtD
Aripiprazole—Malaise—Prednisone—multiple sclerosis	8.43e-05	0.000257	CcSEcCtD
Aripiprazole—Vertigo—Prednisone—multiple sclerosis	8.4e-05	0.000256	CcSEcCtD
Aripiprazole—Eye disorder—Methotrexate—multiple sclerosis	8.39e-05	0.000256	CcSEcCtD
Aripiprazole—Syncope—Prednisone—multiple sclerosis	8.39e-05	0.000256	CcSEcCtD
Aripiprazole—Tinnitus—Methotrexate—multiple sclerosis	8.37e-05	0.000255	CcSEcCtD
Aripiprazole—Anorexia—Betamethasone—multiple sclerosis	8.35e-05	0.000255	CcSEcCtD
Aripiprazole—Anorexia—Dexamethasone—multiple sclerosis	8.35e-05	0.000255	CcSEcCtD
Aripiprazole—Urticaria—Prednisolone—multiple sclerosis	8.34e-05	0.000254	CcSEcCtD
Aripiprazole—Cardiac disorder—Methotrexate—multiple sclerosis	8.33e-05	0.000254	CcSEcCtD
Aripiprazole—Fatigue—Triamcinolone—multiple sclerosis	8.33e-05	0.000254	CcSEcCtD
Aripiprazole—Fatigue—Methylprednisolone—multiple sclerosis	8.31e-05	0.000253	CcSEcCtD
Aripiprazole—Pain—Triamcinolone—multiple sclerosis	8.26e-05	0.000252	CcSEcCtD
Aripiprazole—Loss of consciousness—Prednisone—multiple sclerosis	8.22e-05	0.000251	CcSEcCtD
Aripiprazole—Hypotension—Dexamethasone—multiple sclerosis	8.19e-05	0.00025	CcSEcCtD
Aripiprazole—Hypotension—Betamethasone—multiple sclerosis	8.19e-05	0.00025	CcSEcCtD
Aripiprazole—Angiopathy—Methotrexate—multiple sclerosis	8.15e-05	0.000248	CcSEcCtD
Aripiprazole—Vomiting—Mitoxantrone—multiple sclerosis	8.14e-05	0.000248	CcSEcCtD
Aripiprazole—Immune system disorder—Methotrexate—multiple sclerosis	8.11e-05	0.000247	CcSEcCtD
Aripiprazole—Convulsion—Prednisone—multiple sclerosis	8.1e-05	0.000247	CcSEcCtD
Aripiprazole—Mediastinal disorder—Methotrexate—multiple sclerosis	8.09e-05	0.000247	CcSEcCtD
Aripiprazole—Hypertension—Prednisone—multiple sclerosis	8.07e-05	0.000246	CcSEcCtD
Aripiprazole—Rash—Mitoxantrone—multiple sclerosis	8.07e-05	0.000246	CcSEcCtD
Aripiprazole—Dermatitis—Mitoxantrone—multiple sclerosis	8.07e-05	0.000246	CcSEcCtD
Aripiprazole—Chills—Methotrexate—multiple sclerosis	8.06e-05	0.000246	CcSEcCtD
Aripiprazole—Headache—Mitoxantrone—multiple sclerosis	8.02e-05	0.000245	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	7.99e-05	0.000243	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	7.99e-05	0.000243	CcSEcCtD
Aripiprazole—Arthralgia—Prednisone—multiple sclerosis	7.96e-05	0.000243	CcSEcCtD
Aripiprazole—Myalgia—Prednisone—multiple sclerosis	7.96e-05	0.000243	CcSEcCtD
Aripiprazole—Feeling abnormal—Triamcinolone—multiple sclerosis	7.96e-05	0.000243	CcSEcCtD
Aripiprazole—Feeling abnormal—Methylprednisolone—multiple sclerosis	7.94e-05	0.000242	CcSEcCtD
Aripiprazole—Anxiety—Prednisone—multiple sclerosis	7.93e-05	0.000242	CcSEcCtD
Aripiprazole—Alopecia—Methotrexate—multiple sclerosis	7.93e-05	0.000242	CcSEcCtD
Aripiprazole—Insomnia—Betamethasone—multiple sclerosis	7.93e-05	0.000242	CcSEcCtD
Aripiprazole—Insomnia—Dexamethasone—multiple sclerosis	7.93e-05	0.000242	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	7.91e-05	0.000241	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	7.88e-05	0.00024	CcSEcCtD
Aripiprazole—Paraesthesia—Dexamethasone—multiple sclerosis	7.87e-05	0.00024	CcSEcCtD
Aripiprazole—Paraesthesia—Betamethasone—multiple sclerosis	7.87e-05	0.00024	CcSEcCtD
Aripiprazole—Discomfort—Prednisone—multiple sclerosis	7.87e-05	0.00024	CcSEcCtD
Aripiprazole—Mental disorder—Methotrexate—multiple sclerosis	7.87e-05	0.00024	CcSEcCtD
Aripiprazole—Malnutrition—Methotrexate—multiple sclerosis	7.82e-05	0.000238	CcSEcCtD
Aripiprazole—Erythema—Methotrexate—multiple sclerosis	7.82e-05	0.000238	CcSEcCtD
Aripiprazole—Hypersensitivity—Prednisolone—multiple sclerosis	7.74e-05	0.000236	CcSEcCtD
Aripiprazole—Dyspepsia—Betamethasone—multiple sclerosis	7.72e-05	0.000235	CcSEcCtD
Aripiprazole—Dyspepsia—Dexamethasone—multiple sclerosis	7.72e-05	0.000235	CcSEcCtD
Aripiprazole—Urticaria—Triamcinolone—multiple sclerosis	7.67e-05	0.000234	CcSEcCtD
Aripiprazole—Urticaria—Methylprednisolone—multiple sclerosis	7.66e-05	0.000233	CcSEcCtD
Aripiprazole—Dysgeusia—Methotrexate—multiple sclerosis	7.65e-05	0.000233	CcSEcCtD
Aripiprazole—Body temperature increased—Triamcinolone—multiple sclerosis	7.64e-05	0.000233	CcSEcCtD
Aripiprazole—Anaphylactic shock—Prednisone—multiple sclerosis	7.63e-05	0.000233	CcSEcCtD
Aripiprazole—Oedema—Prednisone—multiple sclerosis	7.63e-05	0.000233	CcSEcCtD
Aripiprazole—Abdominal pain—Methylprednisolone—multiple sclerosis	7.62e-05	0.000232	CcSEcCtD
Aripiprazole—Decreased appetite—Dexamethasone—multiple sclerosis	7.62e-05	0.000232	CcSEcCtD
Aripiprazole—Decreased appetite—Betamethasone—multiple sclerosis	7.62e-05	0.000232	CcSEcCtD
Aripiprazole—Nausea—Mitoxantrone—multiple sclerosis	7.6e-05	0.000232	CcSEcCtD
Aripiprazole—Infection—Prednisone—multiple sclerosis	7.58e-05	0.000231	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	7.57e-05	0.000231	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Betamethasone—multiple sclerosis	7.57e-05	0.000231	CcSEcCtD
Aripiprazole—Back pain—Methotrexate—multiple sclerosis	7.56e-05	0.000231	CcSEcCtD
Aripiprazole—Fatigue—Dexamethasone—multiple sclerosis	7.56e-05	0.00023	CcSEcCtD
Aripiprazole—Fatigue—Betamethasone—multiple sclerosis	7.56e-05	0.00023	CcSEcCtD
Aripiprazole—Shock—Prednisone—multiple sclerosis	7.51e-05	0.000229	CcSEcCtD
Aripiprazole—Pain—Betamethasone—multiple sclerosis	7.5e-05	0.000229	CcSEcCtD
Aripiprazole—Pain—Dexamethasone—multiple sclerosis	7.5e-05	0.000229	CcSEcCtD
Aripiprazole—Nervous system disorder—Prednisone—multiple sclerosis	7.49e-05	0.000228	CcSEcCtD
Aripiprazole—Tachycardia—Prednisone—multiple sclerosis	7.45e-05	0.000227	CcSEcCtD
Aripiprazole—Skin disorder—Prednisone—multiple sclerosis	7.41e-05	0.000226	CcSEcCtD
Aripiprazole—Hyperhidrosis—Prednisone—multiple sclerosis	7.38e-05	0.000225	CcSEcCtD
Aripiprazole—Vision blurred—Methotrexate—multiple sclerosis	7.37e-05	0.000225	CcSEcCtD
Aripiprazole—Anorexia—Prednisone—multiple sclerosis	7.28e-05	0.000222	CcSEcCtD
Aripiprazole—Ill-defined disorder—Methotrexate—multiple sclerosis	7.25e-05	0.000221	CcSEcCtD
Aripiprazole—Anaemia—Methotrexate—multiple sclerosis	7.22e-05	0.00022	CcSEcCtD
Aripiprazole—Feeling abnormal—Dexamethasone—multiple sclerosis	7.22e-05	0.00022	CcSEcCtD
Aripiprazole—Feeling abnormal—Betamethasone—multiple sclerosis	7.22e-05	0.00022	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Dexamethasone—multiple sclerosis	7.17e-05	0.000219	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Betamethasone—multiple sclerosis	7.17e-05	0.000219	CcSEcCtD
Aripiprazole—Hypersensitivity—Triamcinolone—multiple sclerosis	7.12e-05	0.000217	CcSEcCtD
Aripiprazole—Hypersensitivity—Methylprednisolone—multiple sclerosis	7.1e-05	0.000216	CcSEcCtD
Aripiprazole—Malaise—Methotrexate—multiple sclerosis	7.05e-05	0.000215	CcSEcCtD
Aripiprazole—Vertigo—Methotrexate—multiple sclerosis	7.02e-05	0.000214	CcSEcCtD
Aripiprazole—Leukopenia—Methotrexate—multiple sclerosis	7e-05	0.000213	CcSEcCtD
Aripiprazole—Urticaria—Dexamethasone—multiple sclerosis	6.96e-05	0.000212	CcSEcCtD
Aripiprazole—Urticaria—Betamethasone—multiple sclerosis	6.96e-05	0.000212	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Prednisone—multiple sclerosis	6.95e-05	0.000212	CcSEcCtD
Aripiprazole—Dizziness—Prednisolone—multiple sclerosis	6.95e-05	0.000212	CcSEcCtD
Aripiprazole—Asthenia—Triamcinolone—multiple sclerosis	6.93e-05	0.000211	CcSEcCtD
Aripiprazole—Abdominal pain—Dexamethasone—multiple sclerosis	6.93e-05	0.000211	CcSEcCtD
Aripiprazole—Abdominal pain—Betamethasone—multiple sclerosis	6.93e-05	0.000211	CcSEcCtD
Aripiprazole—Body temperature increased—Betamethasone—multiple sclerosis	6.93e-05	0.000211	CcSEcCtD
Aripiprazole—Body temperature increased—Dexamethasone—multiple sclerosis	6.93e-05	0.000211	CcSEcCtD
Aripiprazole—Asthenia—Methylprednisolone—multiple sclerosis	6.92e-05	0.000211	CcSEcCtD
Aripiprazole—Insomnia—Prednisone—multiple sclerosis	6.9e-05	0.00021	CcSEcCtD
Aripiprazole—Paraesthesia—Prednisone—multiple sclerosis	6.85e-05	0.000209	CcSEcCtD
Aripiprazole—Pruritus—Triamcinolone—multiple sclerosis	6.83e-05	0.000208	CcSEcCtD
Aripiprazole—Cough—Methotrexate—multiple sclerosis	6.82e-05	0.000208	CcSEcCtD
Aripiprazole—Pruritus—Methylprednisolone—multiple sclerosis	6.82e-05	0.000208	CcSEcCtD
Aripiprazole—Convulsion—Methotrexate—multiple sclerosis	6.77e-05	0.000206	CcSEcCtD
Aripiprazole—Dyspepsia—Prednisone—multiple sclerosis	6.72e-05	0.000205	CcSEcCtD
Aripiprazole—Chest pain—Methotrexate—multiple sclerosis	6.65e-05	0.000203	CcSEcCtD
Aripiprazole—Arthralgia—Methotrexate—multiple sclerosis	6.65e-05	0.000203	CcSEcCtD
Aripiprazole—Myalgia—Methotrexate—multiple sclerosis	6.65e-05	0.000203	CcSEcCtD
Aripiprazole—Decreased appetite—Prednisone—multiple sclerosis	6.64e-05	0.000202	CcSEcCtD
Aripiprazole—Rash—Prednisolone—multiple sclerosis	6.62e-05	0.000202	CcSEcCtD
Aripiprazole—Dermatitis—Prednisolone—multiple sclerosis	6.62e-05	0.000202	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	6.61e-05	0.000201	CcSEcCtD
Aripiprazole—Diarrhoea—Methylprednisolone—multiple sclerosis	6.59e-05	0.000201	CcSEcCtD
Aripiprazole—Fatigue—Prednisone—multiple sclerosis	6.58e-05	0.000201	CcSEcCtD
Aripiprazole—Headache—Prednisolone—multiple sclerosis	6.58e-05	0.000201	CcSEcCtD
Aripiprazole—Discomfort—Methotrexate—multiple sclerosis	6.57e-05	0.0002	CcSEcCtD
Aripiprazole—Constipation—Prednisone—multiple sclerosis	6.53e-05	0.000199	CcSEcCtD
Aripiprazole—Confusional state—Methotrexate—multiple sclerosis	6.43e-05	0.000196	CcSEcCtD
Aripiprazole—Dizziness—Triamcinolone—multiple sclerosis	6.39e-05	0.000195	CcSEcCtD
Aripiprazole—Anaphylactic shock—Methotrexate—multiple sclerosis	6.38e-05	0.000194	CcSEcCtD
Aripiprazole—Dizziness—Methylprednisolone—multiple sclerosis	6.37e-05	0.000194	CcSEcCtD
Aripiprazole—Infection—Methotrexate—multiple sclerosis	6.34e-05	0.000193	CcSEcCtD
Aripiprazole—Feeling abnormal—Prednisone—multiple sclerosis	6.29e-05	0.000192	CcSEcCtD
Aripiprazole—Asthenia—Betamethasone—multiple sclerosis	6.29e-05	0.000192	CcSEcCtD
Aripiprazole—Asthenia—Dexamethasone—multiple sclerosis	6.29e-05	0.000192	CcSEcCtD
Aripiprazole—Nervous system disorder—Methotrexate—multiple sclerosis	6.26e-05	0.000191	CcSEcCtD
Aripiprazole—Thrombocytopenia—Methotrexate—multiple sclerosis	6.25e-05	0.00019	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Prednisone—multiple sclerosis	6.24e-05	0.00019	CcSEcCtD
Aripiprazole—Nausea—Prednisolone—multiple sclerosis	6.24e-05	0.00019	CcSEcCtD
Aripiprazole—Pruritus—Dexamethasone—multiple sclerosis	6.2e-05	0.000189	CcSEcCtD
Aripiprazole—Pruritus—Betamethasone—multiple sclerosis	6.2e-05	0.000189	CcSEcCtD
Aripiprazole—Skin disorder—Methotrexate—multiple sclerosis	6.2e-05	0.000189	CcSEcCtD
Aripiprazole—Hyperhidrosis—Methotrexate—multiple sclerosis	6.17e-05	0.000188	CcSEcCtD
Aripiprazole—Vomiting—Triamcinolone—multiple sclerosis	6.14e-05	0.000187	CcSEcCtD
Aripiprazole—Vomiting—Methylprednisolone—multiple sclerosis	6.13e-05	0.000187	CcSEcCtD
Aripiprazole—Rash—Triamcinolone—multiple sclerosis	6.09e-05	0.000186	CcSEcCtD
Aripiprazole—Dermatitis—Triamcinolone—multiple sclerosis	6.08e-05	0.000186	CcSEcCtD
Aripiprazole—Anorexia—Methotrexate—multiple sclerosis	6.08e-05	0.000185	CcSEcCtD
Aripiprazole—Rash—Methylprednisolone—multiple sclerosis	6.08e-05	0.000185	CcSEcCtD
Aripiprazole—Dermatitis—Methylprednisolone—multiple sclerosis	6.07e-05	0.000185	CcSEcCtD
Aripiprazole—Urticaria—Prednisone—multiple sclerosis	6.06e-05	0.000185	CcSEcCtD
Aripiprazole—Headache—Triamcinolone—multiple sclerosis	6.05e-05	0.000184	CcSEcCtD
Aripiprazole—Headache—Methylprednisolone—multiple sclerosis	6.04e-05	0.000184	CcSEcCtD
Aripiprazole—Body temperature increased—Prednisone—multiple sclerosis	6.03e-05	0.000184	CcSEcCtD
Aripiprazole—Abdominal pain—Prednisone—multiple sclerosis	6.03e-05	0.000184	CcSEcCtD
Aripiprazole—Diarrhoea—Betamethasone—multiple sclerosis	6e-05	0.000183	CcSEcCtD
Aripiprazole—Diarrhoea—Dexamethasone—multiple sclerosis	6e-05	0.000183	CcSEcCtD
Aripiprazole—Hypotension—Methotrexate—multiple sclerosis	5.96e-05	0.000182	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	5.81e-05	0.000177	CcSEcCtD
Aripiprazole—Dizziness—Dexamethasone—multiple sclerosis	5.8e-05	0.000177	CcSEcCtD
Aripiprazole—Dizziness—Betamethasone—multiple sclerosis	5.8e-05	0.000177	CcSEcCtD
Aripiprazole—Insomnia—Methotrexate—multiple sclerosis	5.77e-05	0.000176	CcSEcCtD
Aripiprazole—Nausea—Triamcinolone—multiple sclerosis	5.74e-05	0.000175	CcSEcCtD
Aripiprazole—Paraesthesia—Methotrexate—multiple sclerosis	5.73e-05	0.000175	CcSEcCtD
Aripiprazole—Nausea—Methylprednisolone—multiple sclerosis	5.72e-05	0.000175	CcSEcCtD
Aripiprazole—Dyspnoea—Methotrexate—multiple sclerosis	5.69e-05	0.000173	CcSEcCtD
Aripiprazole—Somnolence—Methotrexate—multiple sclerosis	5.67e-05	0.000173	CcSEcCtD
Aripiprazole—Hypersensitivity—Prednisone—multiple sclerosis	5.62e-05	0.000171	CcSEcCtD
Aripiprazole—Dyspepsia—Methotrexate—multiple sclerosis	5.62e-05	0.000171	CcSEcCtD
Aripiprazole—Vomiting—Dexamethasone—multiple sclerosis	5.57e-05	0.00017	CcSEcCtD
Aripiprazole—Vomiting—Betamethasone—multiple sclerosis	5.57e-05	0.00017	CcSEcCtD
Aripiprazole—Decreased appetite—Methotrexate—multiple sclerosis	5.55e-05	0.000169	CcSEcCtD
Aripiprazole—Rash—Dexamethasone—multiple sclerosis	5.53e-05	0.000168	CcSEcCtD
Aripiprazole—Rash—Betamethasone—multiple sclerosis	5.53e-05	0.000168	CcSEcCtD
Aripiprazole—Dermatitis—Betamethasone—multiple sclerosis	5.52e-05	0.000168	CcSEcCtD
Aripiprazole—Dermatitis—Dexamethasone—multiple sclerosis	5.52e-05	0.000168	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Methotrexate—multiple sclerosis	5.51e-05	0.000168	CcSEcCtD
Aripiprazole—Fatigue—Methotrexate—multiple sclerosis	5.5e-05	0.000168	CcSEcCtD
Aripiprazole—Headache—Dexamethasone—multiple sclerosis	5.49e-05	0.000167	CcSEcCtD
Aripiprazole—Headache—Betamethasone—multiple sclerosis	5.49e-05	0.000167	CcSEcCtD
Aripiprazole—Asthenia—Prednisone—multiple sclerosis	5.48e-05	0.000167	CcSEcCtD
Aripiprazole—Pain—Methotrexate—multiple sclerosis	5.45e-05	0.000166	CcSEcCtD
Aripiprazole—Pruritus—Prednisone—multiple sclerosis	5.4e-05	0.000165	CcSEcCtD
Aripiprazole—Feeling abnormal—Methotrexate—multiple sclerosis	5.26e-05	0.00016	CcSEcCtD
Aripiprazole—Diarrhoea—Prednisone—multiple sclerosis	5.22e-05	0.000159	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Methotrexate—multiple sclerosis	5.22e-05	0.000159	CcSEcCtD
Aripiprazole—Nausea—Dexamethasone—multiple sclerosis	5.21e-05	0.000159	CcSEcCtD
Aripiprazole—Nausea—Betamethasone—multiple sclerosis	5.21e-05	0.000159	CcSEcCtD
Aripiprazole—Urticaria—Methotrexate—multiple sclerosis	5.07e-05	0.000155	CcSEcCtD
Aripiprazole—Dizziness—Prednisone—multiple sclerosis	5.05e-05	0.000154	CcSEcCtD
Aripiprazole—Body temperature increased—Methotrexate—multiple sclerosis	5.04e-05	0.000154	CcSEcCtD
Aripiprazole—Abdominal pain—Methotrexate—multiple sclerosis	5.04e-05	0.000154	CcSEcCtD
Aripiprazole—Vomiting—Prednisone—multiple sclerosis	4.85e-05	0.000148	CcSEcCtD
Aripiprazole—Rash—Prednisone—multiple sclerosis	4.81e-05	0.000147	CcSEcCtD
Aripiprazole—Dermatitis—Prednisone—multiple sclerosis	4.81e-05	0.000147	CcSEcCtD
Aripiprazole—Headache—Prednisone—multiple sclerosis	4.78e-05	0.000146	CcSEcCtD
Aripiprazole—Hypersensitivity—Methotrexate—multiple sclerosis	4.7e-05	0.000143	CcSEcCtD
Aripiprazole—Asthenia—Methotrexate—multiple sclerosis	4.58e-05	0.00014	CcSEcCtD
Aripiprazole—Nausea—Prednisone—multiple sclerosis	4.53e-05	0.000138	CcSEcCtD
Aripiprazole—Pruritus—Methotrexate—multiple sclerosis	4.51e-05	0.000138	CcSEcCtD
Aripiprazole—Diarrhoea—Methotrexate—multiple sclerosis	4.36e-05	0.000133	CcSEcCtD
Aripiprazole—Dizziness—Methotrexate—multiple sclerosis	4.22e-05	0.000129	CcSEcCtD
Aripiprazole—Vomiting—Methotrexate—multiple sclerosis	4.06e-05	0.000124	CcSEcCtD
Aripiprazole—Rash—Methotrexate—multiple sclerosis	4.02e-05	0.000123	CcSEcCtD
Aripiprazole—Dermatitis—Methotrexate—multiple sclerosis	4.02e-05	0.000123	CcSEcCtD
Aripiprazole—Headache—Methotrexate—multiple sclerosis	4e-05	0.000122	CcSEcCtD
Aripiprazole—Nausea—Methotrexate—multiple sclerosis	3.79e-05	0.000116	CcSEcCtD
Aripiprazole—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	6.97e-06	4.03e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—MMP9—multiple sclerosis	6.96e-06	4.02e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—MMP9—multiple sclerosis	6.95e-06	4.02e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IL2—multiple sclerosis	6.94e-06	4.01e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—POMC—multiple sclerosis	6.92e-06	4e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—MMP9—multiple sclerosis	6.91e-06	3.99e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling by GPCR—IL6—multiple sclerosis	6.9e-06	3.99e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—ALB—multiple sclerosis	6.88e-06	3.98e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	6.86e-06	3.97e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	6.84e-06	3.95e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	6.82e-06	3.94e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CD80—multiple sclerosis	6.8e-06	3.93e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	6.78e-06	3.92e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—MMP9—multiple sclerosis	6.76e-06	3.91e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	6.74e-06	3.89e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	6.71e-06	3.88e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IL2—multiple sclerosis	6.71e-06	3.88e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CD80—multiple sclerosis	6.69e-06	3.87e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CD80—multiple sclerosis	6.68e-06	3.86e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	6.68e-06	3.86e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CD80—multiple sclerosis	6.66e-06	3.85e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—MMP9—multiple sclerosis	6.65e-06	3.85e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IL2—multiple sclerosis	6.64e-06	3.84e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CD80—multiple sclerosis	6.64e-06	3.84e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling by GPCR—IL6—multiple sclerosis	6.61e-06	3.82e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CD80—multiple sclerosis	6.57e-06	3.8e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—MMP9—multiple sclerosis	6.56e-06	3.8e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	6.55e-06	3.79e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	6.54e-06	3.78e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	6.51e-06	3.76e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—POMC—multiple sclerosis	6.46e-06	3.74e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—POMC—multiple sclerosis	6.36e-06	3.68e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	6.35e-06	3.67e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—POMC—multiple sclerosis	6.35e-06	3.67e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—POMC—multiple sclerosis	6.34e-06	3.67e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	6.33e-06	3.66e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL2—multiple sclerosis	6.33e-06	3.66e-05	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—IL6—multiple sclerosis	6.33e-06	3.66e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—POMC—multiple sclerosis	6.33e-06	3.66e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CCL2—multiple sclerosis	6.32e-06	3.66e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—ALB—multiple sclerosis	6.31e-06	3.65e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—POMC—multiple sclerosis	6.31e-06	3.65e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—IL6—multiple sclerosis	6.3e-06	3.64e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—MMP9—multiple sclerosis	6.29e-06	3.63e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL2—multiple sclerosis	6.24e-06	3.61e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—POMC—multiple sclerosis	6.24e-06	3.61e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	6.23e-06	3.6e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	6.23e-06	3.6e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	6.22e-06	3.6e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling by GPCR—IL6—multiple sclerosis	6.21e-06	3.59e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CCL2—multiple sclerosis	6.21e-06	3.59e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	6.19e-06	3.58e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	6.19e-06	3.58e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—STAT3—multiple sclerosis	6.19e-06	3.58e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—STAT3—multiple sclerosis	6.18e-06	3.57e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	6.17e-06	3.57e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—STAT3—multiple sclerosis	6.14e-06	3.55e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	6.11e-06	3.53e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	6.09e-06	3.52e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	6.09e-06	3.52e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	6.09e-06	3.52e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	6.08e-06	3.51e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	6.06e-06	3.5e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	6.04e-06	3.49e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—STAT3—multiple sclerosis	6.01e-06	3.48e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MMP9—multiple sclerosis	5.99e-06	3.46e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	5.98e-06	3.46e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	5.96e-06	3.45e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—STAT3—multiple sclerosis	5.92e-06	3.42e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MMP9—multiple sclerosis	5.91e-06	3.42e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—STAT3—multiple sclerosis	5.84e-06	3.37e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	5.79e-06	3.35e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—ALB—multiple sclerosis	5.78e-06	3.34e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—MYC—multiple sclerosis	5.75e-06	3.32e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TYK2—multiple sclerosis	5.74e-06	3.32e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—MYC—multiple sclerosis	5.74e-06	3.32e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—TGFB1—multiple sclerosis	5.74e-06	3.32e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—TGFB1—multiple sclerosis	5.73e-06	3.31e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—MYC—multiple sclerosis	5.71e-06	3.3e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—BCHE—multiple sclerosis	5.7e-06	3.3e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—TGFB1—multiple sclerosis	5.69e-06	3.29e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL2—multiple sclerosis	5.69e-06	3.29e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	5.66e-06	3.27e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	5.66e-06	3.27e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	5.65e-06	3.27e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	5.65e-06	3.27e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TYK2—multiple sclerosis	5.64e-06	3.26e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	5.64e-06	3.26e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—MAPK1—multiple sclerosis	5.62e-06	3.25e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	5.62e-06	3.25e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—MAPK1—multiple sclerosis	5.62e-06	3.25e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	5.61e-06	3.24e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	5.6e-06	3.24e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—IL6—multiple sclerosis	5.6e-06	3.24e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—STAT3—multiple sclerosis	5.59e-06	3.23e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—MYC—multiple sclerosis	5.59e-06	3.23e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—MAPK1—multiple sclerosis	5.58e-06	3.23e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—TGFB1—multiple sclerosis	5.57e-06	3.22e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—APOE—multiple sclerosis	5.57e-06	3.22e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	5.55e-06	3.21e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	5.54e-06	3.2e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	5.53e-06	3.2e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—MYC—multiple sclerosis	5.5e-06	3.18e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—TGFB1—multiple sclerosis	5.48e-06	3.17e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—MAPK1—multiple sclerosis	5.47e-06	3.16e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL2—multiple sclerosis	5.44e-06	3.15e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—MYC—multiple sclerosis	5.42e-06	3.14e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	5.42e-06	3.13e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL2—multiple sclerosis	5.41e-06	3.13e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—TGFB1—multiple sclerosis	5.41e-06	3.13e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	5.39e-06	3.11e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	5.39e-06	3.11e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—MAPK1—multiple sclerosis	5.38e-06	3.11e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	5.34e-06	3.09e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—STAT3—multiple sclerosis	5.33e-06	3.08e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—MAPK1—multiple sclerosis	5.31e-06	3.07e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	5.27e-06	3.04e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—STAT3—multiple sclerosis	5.25e-06	3.04e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—APOE—multiple sclerosis	5.25e-06	3.03e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—MYC—multiple sclerosis	5.25e-06	3.03e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	5.24e-06	3.03e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	5.24e-06	3.03e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—MYC—multiple sclerosis	5.19e-06	3e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	5.18e-06	3e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TGFB1—multiple sclerosis	5.18e-06	3e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	5.16e-06	2.98e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	5.15e-06	2.98e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	5.14e-06	2.97e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	5.13e-06	2.97e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	5.12e-06	2.96e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—MAPK1—multiple sclerosis	5.08e-06	2.94e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	4.98e-06	2.88e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MYC—multiple sclerosis	4.95e-06	2.86e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TGFB1—multiple sclerosis	4.94e-06	2.85e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	4.91e-06	2.84e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MYC—multiple sclerosis	4.88e-06	2.82e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TGFB1—multiple sclerosis	4.87e-06	2.82e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MAPK1—multiple sclerosis	4.84e-06	2.8e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	4.79e-06	2.77e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—POMC—multiple sclerosis	4.79e-06	2.77e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL2—multiple sclerosis	4.78e-06	2.76e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MAPK1—multiple sclerosis	4.78e-06	2.76e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—IL6—multiple sclerosis	4.75e-06	2.75e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	4.74e-06	2.74e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL2—multiple sclerosis	4.7e-06	2.72e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL2—multiple sclerosis	4.69e-06	2.71e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	4.68e-06	2.7e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL2—multiple sclerosis	4.68e-06	2.7e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—IL6—multiple sclerosis	4.67e-06	2.7e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL2—multiple sclerosis	4.66e-06	2.7e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	4.65e-06	2.69e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	4.64e-06	2.68e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL2—multiple sclerosis	4.62e-06	2.67e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	4.6e-06	2.66e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	4.59e-06	2.66e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	4.58e-06	2.65e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	4.58e-06	2.65e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	4.56e-06	2.63e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MMP9—multiple sclerosis	4.52e-06	2.61e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—POMC—multiple sclerosis	4.51e-06	2.61e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	4.45e-06	2.57e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MYC—multiple sclerosis	4.45e-06	2.57e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MMP9—multiple sclerosis	4.44e-06	2.57e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	4.44e-06	2.57e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	4.43e-06	2.56e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	4.43e-06	2.56e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	4.41e-06	2.55e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	4.41e-06	2.55e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	4.4e-06	2.54e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	4.37e-06	2.53e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—ALB—multiple sclerosis	4.36e-06	2.52e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	4.36e-06	2.52e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	4.36e-06	2.52e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	4.35e-06	2.52e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—IL6—multiple sclerosis	4.32e-06	2.5e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—IL6—multiple sclerosis	4.32e-06	2.5e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	4.31e-06	2.49e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—IL6—multiple sclerosis	4.29e-06	2.48e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	4.28e-06	2.47e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	4.26e-06	2.46e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MYC—multiple sclerosis	4.26e-06	2.46e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	4.25e-06	2.45e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MYC—multiple sclerosis	4.23e-06	2.45e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	4.22e-06	2.44e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—IL6—multiple sclerosis	4.2e-06	2.43e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	4.16e-06	2.41e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	4.14e-06	2.39e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—IL6—multiple sclerosis	4.13e-06	2.39e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	4.12e-06	2.38e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—ALB—multiple sclerosis	4.11e-06	2.38e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	4.11e-06	2.38e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IL6—multiple sclerosis	4.08e-06	2.36e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	4.05e-06	2.34e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	4.05e-06	2.34e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	4.04e-06	2.34e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	4.03e-06	2.33e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—STAT3—multiple sclerosis	4.02e-06	2.32e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	3.96e-06	2.29e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	3.96e-06	2.29e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—STAT3—multiple sclerosis	3.95e-06	2.28e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IL6—multiple sclerosis	3.94e-06	2.28e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	3.94e-06	2.28e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	3.92e-06	2.27e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IL6—multiple sclerosis	3.9e-06	2.26e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	3.88e-06	2.25e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	3.87e-06	2.24e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MYC—multiple sclerosis	3.74e-06	2.16e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	3.73e-06	2.16e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL6—multiple sclerosis	3.72e-06	2.15e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MYC—multiple sclerosis	3.68e-06	2.13e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL6—multiple sclerosis	3.67e-06	2.12e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MYC—multiple sclerosis	3.67e-06	2.12e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	3.67e-06	2.12e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	3.66e-06	2.12e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MYC—multiple sclerosis	3.66e-06	2.11e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	3.66e-06	2.11e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	3.65e-06	2.11e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MYC—multiple sclerosis	3.65e-06	2.11e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	3.64e-06	2.1e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MYC—multiple sclerosis	3.61e-06	2.09e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	3.6e-06	2.08e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	3.6e-06	2.08e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	3.6e-06	2.08e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	3.6e-06	2.08e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	3.59e-06	2.08e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	3.59e-06	2.07e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	3.58e-06	2.07e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	3.57e-06	2.06e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	3.53e-06	2.04e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	3.52e-06	2.04e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APOE—multiple sclerosis	3.43e-06	1.98e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	3.34e-06	1.93e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL6—multiple sclerosis	3.34e-06	1.93e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	3.34e-06	1.93e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	3.31e-06	1.92e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	3.27e-06	1.89e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL6—multiple sclerosis	3.2e-06	1.85e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL6—multiple sclerosis	3.18e-06	1.84e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	3.1e-06	1.79e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	3.05e-06	1.76e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—POMC—multiple sclerosis	2.95e-06	1.7e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL6—multiple sclerosis	2.81e-06	1.62e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL6—multiple sclerosis	2.76e-06	1.6e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL6—multiple sclerosis	2.76e-06	1.59e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL6—multiple sclerosis	2.75e-06	1.59e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL6—multiple sclerosis	2.74e-06	1.58e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL6—multiple sclerosis	2.71e-06	1.57e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	2.71e-06	1.56e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ALB—multiple sclerosis	2.69e-06	1.55e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	2.51e-06	1.45e-05	CbGpPWpGaD
